Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642KFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 25 | Alam KamranCHIEF FINANCIAL OFFICER |  TSHATaysha Gene Therapies, Inc.Open-market sale | SELL | $110K 23.8K sh | Jan 27, 2026 |
| 24 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.56M 51.9K sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $144K 524 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $117K 421 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $119K 429 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $64K 227 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 23 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $74K 263 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $145K 514 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $283 1 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $17K 62 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $3,360 12 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $30K 107 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 18 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $244K 8,135 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 15 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER |  LTHLife Time Group Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $360K 12.1K sh | Jan 27, 2026 traded Jan 23, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $47K 168 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $567 2 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $8,904 32 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $20K 71 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $364K 2,663 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 |  Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $364K 2,664 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $265K 1,913 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $270K 1,988 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $270K 1,987 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $265K 1,914 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $131K 951 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $131K 950 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $6,652 50 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $6,652 50 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector |  SCHWSCHWAB CHARLES CORPOpen-market sale | SELL | $1.00M 9,525 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations |  MUMICRON TECHNOLOGY INCOpen-market sale | SELL | $1.99M 5,128 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector | SCHWSCHWAB CHARLES CORP Open-market sale | SELL | $1.00M 9,525 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $2.81M 7,200 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $3.32M 8,500 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector | SCHWSCHWAB CHARLES CORP Open-market sale | SELL | $2.00M 19.1K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 33 | Tpg Gp A, Llc10% Owner |  SIONSionna Therapeutics, Inc.Open-market sale | SELL | $10.00M 250.0K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 33 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale | SELL | $777K 1,577 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 32 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $511K 1,295 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Wilson Kelli AnnEVP Chief Banking Officer |  HFWAHERITAGE FINANCIAL CORP /WA/Open-market sale | SELL | $50K 1,900 sh | Jan 26, 2026 traded Jan 26, 2026 |